Хаха, па погоре ти покажав. Ти ја сврте (спин) на тоа дека има многу други подвидови или да те цитирам "Сето тоа се однесува на намалување на инфекции со тие тие 4 подвидови HPV, или јас да ти преведам тебе..."
А јас ти праќам дека тие видови се главните кои докажано предизвикуваат разни типови рак. Што во превод (пак) значи дека вакцината ќе те заштити од најголемите причинители. А податоците кои ги болдирав покажуваат дека истражувањата докажуваат дека тоа и го прави.
И сега ми праќаш пак дека бараш податоци и статистика.
WTF?
How effective are HPV vaccines?
HPV vaccines are highly effective in preventing infection with the types of HPV they target when given before initial exposure to the virus—which means before individuals begin to engage in sexual activity.
In the trials that led to the approval of Gardasil and Cervarix, these vaccines were found to provide nearly 100% protection against persistent cervical infections with HPV types 16 and 18 and the cervical cell changes that these persistent infections can cause. Gardasil 9 is as effective as Gardasil for the prevention of diseases caused by the four shared HPV types (6, 11, 16, and 18), based on similar antibody responses in participants in clinical studies. The trials that led to approval of Gardasil 9 found it to be nearly 100% effective in preventing cervical, vulvar, and vaginal disease caused by the five additional HPV types (31, 33, 45, 52, and 58) that it targets (4). In a 2017 position paper, the World Health Organization stated that the HPV vaccines have equivalent efficacy (5). The Cervarix vaccine has been found to provide partial protection against a few additional HPV types not included in the vaccine that can cause cancer, a phenomenon called cross-protection (6).
To date, protection against the targeted HPV types has been found to last for at least 10 years with Gardasil (7), at least 9 years with Cervarix (
, and at least 6 years with Gardasil 9 (9). Long-term studies of vaccine efficacy that are still in progress will help scientists better understand the total duration of protection.
A clinical trial of Gardasil in men indicated that it can prevent anal cell changes caused by persistent infection and genital warts (10). Analyses of data from women participating in a clinical trial of Cervarix found that this vaccine can protect women against persistent HPV 16 and 18 infections in the anus (11) and the oral cavity (12)